» Articles » PMID: 10203703

Phosphorylcholine: Friend or Foe of the Immune System?

Overview
Journal Immunol Today
Date 1999 Apr 22
PMID 10203703
Citations 53
Authors
Affiliations
Soon will be listed here.
Abstract

Phosphorylcholine (PC) is a structural component of a variety of prokaryotic and eukaryotic pathogens. In some cases, PC in infectious agents can benefit the infected host due to its targeting by both the innate and adaptive immune responses. However, as discussed here, PC exhibits a surprising range of immunomodulatory properties that might be to the detriment of the host.

Citing Articles

Antibodies Against Phosphorylcholine in Prediction of Cardiovascular Disease Among Women: A Population-Based Prospective Cohort Study.

Frostegard J, Akesson A, Helte E, Soderlund F, Su J, Hua X JACC Adv. 2025; 3(11):101298.

PMID: 39741640 PMC: 11686053. DOI: 10.1016/j.jacadv.2024.101298.


Circulatory Metabolite Ratios as Indicators of Lifestyle Risk Factors Based on a Greek NAFLD Case-Control Study.

Fotakis C, Amanatidou A, Kafyra M, Andreou V, Kalafati I, Zervou M Nutrients. 2024; 16(8).

PMID: 38674925 PMC: 11055137. DOI: 10.3390/nu16081235.


Supramolecular Peptide Self-Assemblies Facilitate Oral Immunization.

Curvino E, Woodruff M, Roe E, Freire Haddad H, Alvarado P, Collier J ACS Biomater Sci Eng. 2024; 10(5):3041-3056.

PMID: 38623037 PMC: 11382288. DOI: 10.1021/acsbiomaterials.4c00525.


Increased specificity of Fasciola hepatica excretory-secretory antigens combining negative selection on hydroxyapatite and salt precipitation.

Ubeira F, Gonzalez-Warleta M, Martinez-Sernandez V, Castro-Hermida J, Paniagua E, Romaris F Sci Rep. 2024; 14(1):3897.

PMID: 38365880 PMC: 10873304. DOI: 10.1038/s41598-024-54290-8.


Engaging natural antibody responses for the treatment of inflammatory bowel disease via phosphorylcholine-presenting nanofibres.

Curvino E, Roe E, Freire Haddad H, Anderson A, Woodruff M, Votaw N Nat Biomed Eng. 2023; 8(5):628-649.

PMID: 38012308 PMC: 11128482. DOI: 10.1038/s41551-023-01139-6.